Allurion Technologies Files 8-K on Shareholder Vote and Financials
Ticker: ALURW · Form: 8-K · Filed: Dec 18, 2024 · CIK: 1964979
Sentiment: neutral
Topics: corporate-action, financials, warrants
TL;DR
Allurion filed an 8-K detailing shareholder votes and financials, including warrant info.
AI Summary
Allurion Technologies, Inc. filed an 8-K on December 18, 2024, reporting on a submission of matters to a vote of security holders and financial statements. The filing details the company's common stock par value and warrants to purchase shares. The report was filed as of December 16, 2024.
Why It Matters
This filing provides updates on corporate actions and financial reporting, which are crucial for investors to understand the company's current status and potential future developments.
Risk Assessment
Risk Level: low — This is a routine filing reporting on corporate actions and financial statements, not indicating any immediate operational or financial distress.
Key Numbers
- 14,204,555 — Warrants to Purchase Shares (Details the number of shares covered by outstanding warrants.)
- $8.10 — Exercise Price (Specifies the price at which warrants can be exercised.)
Key Players & Entities
- Allurion Technologies, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- 001-41767 (company_id) — Commission File Number
- 92-2182207 (company_id) — IRS Employer Identification No.
- 11 Huron Drive (address) — Business Address
- Natick (city) — Business Address City
- Massachusetts (state) — Business Address State
- 01760 (zip_code) — Business Address Zip
- 20241216 (date) — Date of earliest event reported
- 20241218 (date) — Date of Report
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates 'Submission of Matters to a Vote of Security Holders' as an item, but the specific details of the vote are not provided in this excerpt.
What are the details of the warrants mentioned in the filing?
The filing mentions warrants to purchase 14,204,555 shares of common stock, each at an exercise price of $8.10 per share.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated December 16, 2024.
What is the par value of Allurion Technologies' common stock?
The par value of Allurion Technologies' common stock is $0.00001 per share.
What is the company's primary business classification?
Allurion Technologies, Inc. is classified under 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS' with SIC code 3841.
Filing Stats: 868 words · 3 min read · ~3 pages · Grade level 12.6 · Accepted 2024-12-18 17:28:35
Key Financial Figures
- $0.0001 — ch registered Common stock, par value $0.0001 per share ALUR The New York Stock E
- $8.10 — mon stock, each at an exercise price of $8.10 per share of common stock ALUR WS T
Filing Documents
- alur-20241216.htm (8-K) — 91KB
- 0000950170-24-137992.txt ( ) — 243KB
- alur-20241216.xsd (EX-101.SCH) — 47KB
- alur-20241216_htm.xml (XML) — 7KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. On December 16, 2024, Allurion Technologies, Inc. (the "Company") reconvened its previously adjourned 2024 Annual Meeting of Stockholders (the "Annual Meeting") to consider and vote on six proposals, each of which is described in detail in the Company's Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on November 8, 2024 (the "Proxy Statement"). The following actions were taken at the Annual Meeting: 1. Proposal 1: The following three nominees were re-elected to serve as Class I directors on the Company's Board of Directors (the "Board") until the Company's 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified, based on the following votes: Nominee Votes For Withheld Broker Non-Votes Shantanu Gaur, M.D. 33,679,178 3,498,179 4,189,522 Krishna Gupta 27,155,018 10,022,339 4,189,522 Nicholas Lewin 33,537,846 3,639,511 4,189,522 2. Proposal 2: The stockholders approved an amendment to the Company's Amended and Restated Certificate of Incorporation to combine the outstanding shares of the Company's common stock into a lesser number of outstanding shares, by a ratio of not less than 1-for-10 and not more than 1-for-25, with the exact ratio to be set within this range by the Board in its sole discretion. The results of such vote were as follows: Votes For Votes Against Abstentions Broker Non-Votes 39,926,423 1,291,769 148,687 0 3. Proposal 3: The stockholders approved the issuance of shares of common stock upon conversion of the Notes pursuant to the Note Purchase Agreement (as such terms are defined in the Proxy Statement) to comply with New York Stock Exchange ("NYSE") Listing Rule 312.03(b)(i). The results of such vote were as follows: Votes For Votes Against Abstentions Broker Non-Votes 33,638,672 2,017,402 1,521,283 4,189,522 4. Proposal 4
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ALLURION TECHNOLOGIES, INC. Date: December 18, 2024 By: /s/ Brendan Gibbons Name: Title: Brendan Gibbons Chief Legal Officer